The Rare Disease CRO for Biotech, Powered by Technology
Delivering faster, better, cheaper rare disease trial results for biotech sponsors
Scientific Advisory Board
Vial CRO is supported by a team of Scientific Advisors who review and provide input on the strategy and direction of the CRO in order to build the infrastructure to advance Gastroenterology research.
Powered By Our Connected Technology Platform
The Vial Technology Platform leverages connected systems and intuitive design to run global trials efficiently at scale
Vial’s modern technology platform brings clinical trials out of the paper stone age, allowing for streamlined processes inside one end-to-end system.
No-Nonsense Pricing
Vial offers sponsors fixed-pricing
agreements with no change orders — ever.
Flat-rate pricing
Zero change orders
Risk-share
on commitments
Accountability
on commitments
A fixed-fee pricing model guarantees a set budget for the entirety of a project, regardless of the time and expense that accrues. Vial reserves the right to modify pricing in accordance with amendments to the study design or protocol.
Vial offers fixed upfront pricing to benefit sponsors:
- Align Incentives
- Transparent budget visibility
- No unexpected charges/fees
- Shared accountability on commitments
- Build trust and deepen the relationship
- Experienced team committed to timelines
- Next-generation technology to streamline workflows and process
- A renowned scientific advisory board providing expert insight
- Deep industry relationships and a preferred site network provide an insider view on trial pain points, allowing us to target and prepare to prevent common errors or delays
Modern Recruiting Platform
We recruit patients across multiple channels and convert them to randomizations — radically reducing enrollment periods
We use the most effective digital tools to reach, screen, and enroll motivated subjects quicker. Our optimized process can cut recruitment times in half.
EMR Integrations
HIPAA compliant automated data pulls and Inclusion/Exclusion reviews.
Fast Start-up and Consolidated Site Activation
Vial’s Site Startup App enables sites to seamlessly onboard to our trials
The results: Lightning fast onboarding for sites to be activated in as few as 30 days.
Tech-Enabled Remote Monitoring Part 1
Download the Vial CRO's white paper to learn more about each stakeholder’s benefits of tech-enabled trials.
Tech-Enabled Remote Monitoring Part 2
Download the Vial CRO's white paper to learn more about each stakeholder’s benefits of tech-enabled trials.
Vial’s Deployment of Modern, Intuitive Electronic Source
Download the Vial CRO's latest white paper to learn how utilizing eSource in clinical trials can streamline process, increase efficiency, and minimize...
Developing Treatments That Matter
Rare diseases affect a small percentage of the population and often have few treatments.
Rare diseases can be severe, life-threatening, and disabling, causing significant emotional and financial strain on affected individuals and their families. Vial offers faster, more efficient clinical trials that enable scientists to develop effective therapies to improve patients' quality of life, slow disease progression, or even cure the disease.
Indications
Multifaceted Clinical Trial Execution Across Rare Disease Indications and Phases
- Amyotrophic lateral sclerosis (ALS)
- Huntington's disease
- Duchenne muscular dystrophy
- Cystic fibrosis
- Fabry disease
- Gaucher disease
- Pompe disease
- Niemann-Pick disease
- Tay-Sachs disease
- Batten disease
- Epidermolysis bullosa
- Ataxia-telangiectasia
- Hermansky-Pudlak syndrome
- Sickle cell disease
- Angelman syndrome
- Rett syndrome
- Dravet syndrome
- Neurofibromatosis
- Marfan syndrome
- Ehlers-Danlos syndrome
Connect with us.
Interested in receiving a proposal from Vial? Leave us a message and some of your contact info and we’ll be in touch with you shortly.
